BioNTech SE BNTX
NASDAQ BNTX
$87.65 +0.44 (+0.50%)
At close: Nov 11, 2026 · 4:00 PM EST

BioNTech SE (BNTX) Net Income Attributable to Noncontrolling Interests (2018 - 2019)

Updated

BioNTech SE's Net Income Attributable to Noncontrolling Interests came in at $17,710 for Q4 2019, compared with -$138,109 a year earlier.

Analysis

BioNTech SE (BNTX) Net Income Attributable to Noncontrolling Interests (2018 - 2019) Analysis & Trends

For FY2019, BioNTech SE's Net Income Attributable to Noncontrolling Interests was -$111,993.

  • Going back by year, Net Income Attributable to Noncontrolling Interests was -$287,063 in FY2018 and -$335,411 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.00 Mn
10 BioNTech SE 22.05 Bn -37.46 Bn 1.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 17,710.20
Mar 31, 2019 -131,848.95
Dec 31, 2018 -138,108.97
Sep 30, 2018 -54,667.07
API Access

BioNTech SE Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BNTX&period=max&api_key=YOUR_API_KEY